Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
Wolfgang Strube, Aslihan Aksar, Ingrid Bauer, Susana Barbosa, Michael Benros, Christiane Blankenstein, Mattia Campana, Laetitia Davidovic, Nicolas Glaichenhaus, Peter Falkai, Thomas Görlitz, Maximilian Hansbauer, Daniel Heilig, Olfa Khalfallah, Marion Leboyer, Emanuela Martinuzzi, Susanne Mayer, Joanna Moussiopoulou, Irina Papazova, Natasa Perić, Elias Wagner, Thomas Schneider-Axmann, Judit Simon, Alkomiet Hasan
Journal of neural transmission (Vienna, Austria : 1996) 2023;130(8):1039-1048